Medicine Prices in Developing Countries

This chapter focuses on the issue of medicine prices in developing countries, examining the challenges, strategies, policies, facilitators, barriers, and recommendations to improve access to affordable medications. This chapter highlights the significant variations in medicine prices across developing countries and the resulting financial burden on individuals and households. It explores the role of factors such as intellectual property rights, generic medicine utilization, local production, and regulatory frameworks in shaping medicine prices. This chapter emphasizes the importance of implementing effective pricing policies, including price regulation, reference pricing, and differential pricing strategies, to ensure fairness and affordability. It also underscores the significance of strengthening health systems, promoting competition, and enhancing transparency in medicine pricing. Collaborative efforts with international organizations, donor agencies, and regional collaborations are identified as facilitators for improving medicine prices. Recommendations include promoting generic medicine use, supporting local production, strengthening medicine procurement systems, and advocating for intellectual property rights flexibilities. This chapter concludes that addressing medicine prices in developing countries requires a comprehensive approach that considers the unique context of each country. The implementation of evidence-based strategies and policies, supported by research and continuous monitoring, is crucial to achieve sustainable access to affordable medicines, reduce health disparities, and enhance the overall health outcomes of populations in developing countries.